Anita Mahadevan-Jansen

Nashville, TN, United States of America

Anita Mahadevan-Jansen

This inventor holds 33 USPTO granted patents and 15 published patent applications and 4 EPO patents, primarily in Optical Spectroscopy. Top assignees: Vanderbilt University, The University of Texas System, Ai Biomed Corp.. Active years: 1998-2026.

USPTO Granted Patents = 33 

% Patents Active = 75.8

 

Average Co-Inventor Count = 3.6

ph-index = 11

Forward Citations = 1,010(Granted Patents)


Location History:

  • Austin, TX (US) (1998 - 2001)
  • Nashville, TN (US) (2002 - 2024)

Company Filing History:


Years Active: 1998-2026

Loading Chart...
Loading Chart...
Areas of Expertise:
Fluorescence Imaging
Optical Fiber
Raman Spectroscopy
Laser Speckle Contrast
Surgical Guidance
Nerve Visualization
Tumor Assessment
Intraoperative Imaging
Tissue Diagnostics
Anatomical Guidance
Microprobe
Optical Stimulation
33 patents (USPTO):Explore Patents

Title: The Innovative Journey of Anita Mahadevan-Jansen

Introduction: Anita Mahadevan-Jansen is a pioneering inventor based in Nashville, TN, known for her groundbreaking work in the field of biomedical optics and medical device innovations.

Latest Patents: Anita Mahadevan-Jansen holds several patents related to optical technologies for medical applications, including advancements in cancer detection and treatment.

Career Highlights: With a distinguished career spanning over two decades, Anita Mahadevan-Jansen has made significant contributions to the development of non-invasive medical devices that have revolutionized the healthcare industry.

Collaborations: Throughout her career, Anita Mahadevan-Jansen has collaborated with leading researchers, medical professionals, and industry experts to further the advancement of optical technologies in healthcare.

Conclusion: Anita Mahadevan-Jansen's dedication to innovation and her commitment to improving patient care through cutting-edge technologies have solidified her reputation as a trailblazing inventor in the field of biomedical optics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…